Initial dose: Hydralazine 37.5 mg-Isosorbide dinitrate 20 mg orally three times a day
Maximum dose: Hydralazine 75 mg-Isosorbide dinitrate 40 mg orally three times a day
Comments:
May titrate up every 3 to 5 days, but some patients may experience side effects and take longer to reach their maximum tolerated dose.
May decrease as low as hydralazine 18.75 mg-isosorbide dinitrate 10 mg three times a day if intolerable side effects occur; should titrate up as soon as side effects subside.
Use: Treatment of heart failure as an adjunct to standard therapy in self-identified black patients to improve survival, prolong time to hospitalization for heart failure, and improve patient-reported functional status. Experience in patients with New York Heart Association (NYHA) class IV heart failure is limited.
Renal Dose Adjustments
No adjustment recommended
Liver Dose Adjustments
Dose adjustment(s) may be required; however, no specific guidelines have been suggested. Caution is recommended.
Precautions
Safety and efficacy have not been established in patients younger than 18 years.
Consult WARNINGS section for additional precautions.
